SCHEMBL2483572

SCHEMBL2483572

NC(=O)c1cnc(Cl)cc1NCc1ccc(Cl)c(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 5/20 0.54
AURKA O14965 2/20 0.54
CD38 P28907 1/20 0.53
JAK3 P52333 3/20 0.48
IRAK4 Q9NWZ3 2/20 0.48
JAK2 O60674 1/20 0.48
JAK1 P23458 1/20 0.48
TYK2 P29597 1/20 0.48
TSHR P16473 2/20 0.47
FFAR1 O14842 1/20 0.44
SSTR3 P32745 1/20 0.44
STAT6 P42226 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
AKT1 P31749 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2479527 0.86 JAK3 (0.53) RPS6KB1CD38JAK3IRAK4JAK2
SCHEMBL12456545 0.85 JAK3 (0.52) RPS6KB1AURKACD38JAK3IRAK4
SCHEMBL2477650 0.85 RPS6KB1 (0.52) RPS6KB1AURKACD38JAK3IRAK4
SCHEMBL2482122 0.84 RPS6KB1 (0.52) RPS6KB1AURKACD38JAK3IRAK4
SCHEMBL2479053 0.84 KDM4E (0.51) CD38JAK3IRAK4JAK2JAK1
SCHEMBL2480282 0.84 JAK3 (0.67) RPS6KB1CD38JAK3IRAK4JAK2
SCHEMBL2478473 0.84 JAK3 (0.51) RPS6KB1CD38JAK3IRAK4JAK2
SCHEMBL2482471 0.83 RPS6KB1 (0.60) RPS6KB1AURKACD38JAK3IRAK4
SCHEMBL12280211 0.83 CDC7 (0.53) RPS6KB1JAK3IRAK4JAK2JAK1
SCHEMBL12456033 0.82 RPS6KB1 (0.54) RPS6KB1AURKACD38JAK3IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575153-B2 Pyridine-3-carboxyamide derivative KOWA COMPANY, LTD. (JP) 2013-11-05 US disclosed
US-8575153-B2 Pyridine-3-carboxyamide derivative KOWA COMPANY, LTD. (JP) 2013-11-05 US disclosed
US-8575153-B2 Pyridine-3-carboxyamide derivative KOWA COMPANY, LTD. (JP) 2013-11-05 US disclosed
EP-2380877-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE Kowa Company, Ltd. (JP) 2011-10-26 EP disclosed
EP-2380877-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE Kowa Company, Ltd. (JP) 2011-10-26 EP disclosed
CN-102227409-A Pyridine-3-carboxyamide derivative KOWA CO 2011-10-26 CN disclosed
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE KOWA COMPANY, LTD. (JP) 2011-09-29 US disclosed
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE KOWA COMPANY, LTD. (JP) 2011-09-29 US disclosed
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE KOWA COMPANY, LTD. (JP) 2011-09-29 US disclosed
WO-2010061971-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE 興和株式会社 (JP) 2010-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE JAK3, JAK1, UACA RPS6KB1 3316/4885AURKA 971/4885CD38 3561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.